甲泼尼龙和利多卡因治疗难治性突发性聋伴耳鸣的效果

doi:10.3760/cma.j.issn.1007-1245.2022.06.012

国际医药卫生导报 ›› 2022, Vol. 28 ›› Issue (6): 780-783.DOI: 10.3760/cma.j.issn.1007-1245.2022.06.012

甲泼尼龙和利多卡因治疗难治性突发性聋伴耳鸣的效果

李富云薛麦富

焦作市妇幼保健院耳鼻咽喉科，焦作　454000

收稿日期:2021-11-03 出版日期:2022-03-15 发布日期:2022-04-15
通讯作者: 李富云，Email：lifuuyun@126.com
基金资助:
河南省医学科技攻关项目（201701214）

Therapeutic effect of methylprednisolone combined with lidocaine for refractory sudden deafness with tinnitus

Li Fuyun, Xue Maifu

Department of Otorhinolaryngology, Maternity and Child Health Hospital of Jiaozuo City, Jiaozuo 454000, China

Received:2021-11-03 Online:2022-03-15 Published:2022-04-15
Contact: Li Fuyun, Email: lifuuyun@126.com
Supported by:
Medical Science and Technology Project of Henan Province (201701214)

摘要/Abstract

摘要： 目的　探析甲泼尼龙和利多卡因在难治性突发性聋伴耳鸣中的治疗效果，及对纯音听阈均值、不良反应的影响。方法　回顾性分析，选择2020年1月至2021年9月焦作市妇幼保健院收治的难治性突发性聋伴耳鸣患者160例作为研究对象，按随机数字表法分为对照组和观察组，各80例。对照组男45例、女35例，年龄（50.52±3.82）岁，采用常规治疗；观察组男41例、女39例，年龄（50.98±3.99）岁，在常规治疗基础上行甲泼尼龙和利多卡因进行联合治疗。对比两组耳功能改善情况、不良反应及用药效果。计量资料组间比较采用独立样本t检验，组内采用配对t检验，计数资料采用χ²检验。结果　治疗前，两组难治性突发性聋伴耳鸣患者纯音听阈均值、耳鸣致残量表（THI）评分比较，差异均无统计学意义（均P>0.05）；治疗后，观察组纯音听阈均值、THL评分分别为（40.03±3.55）dB、（13.85±2.01）分，均低于对照组的（51.95±4.14）dB、（19.95±2.75）分，差异均有统计学意义（均P<0.05）。两组难治性突发性聋伴耳鸣患者不良反应发生率比较，差异无统计学意义（χ²=0.826，P=0.363）。观察组治疗后总有效率为98.75%（79/80），高于对照组90.00%（72/80），差异有统计学意义（χ²=4.238，P=0.040）。结论　将甲泼尼龙与利多卡因联合用药方式在难治性突发性聋伴耳鸣患者的临床治疗中，能促进听力下降、耳鸣等症状的改善与恢复，对降低患者的不良反应发生风险、提升患者的用药疗效均有重要作用，值得推广应用。

关键词: 难治性突发性聋, 耳鸣, 甲泼尼龙, 利多卡因, 治疗效果, 纯音听阈均值

Abstract: Objective　To analyze the therapeutic effect of methylprednisolone combined with lidocaine in refractory sudden deafness with tinnitus, and its influence on the mean value of pure tone hearing threshold and adverse reactions. Methods　In the retrospective analysis, 160 patients with refractory sudden deafness with tinnitus admitted to Maternity and Child Health Hospital of Jiaozuo City from January 2020 to September 2021 were selected as the research objects. According to the random number table method, they were divided into a control group (80 cases) and an observation group (80 cases). In the control group, there were 45 males and 35 females, with an age of (50.52±3.82) years old; there were 41 males and 39 females in the observation group, with an age of (50.98±3.99) years old. Both groups received conventional treatment, and the observation group was given methylprednisolone and lidocaine for combined treatment. The improvement of ear function, adverse reactions, and medication effects of the two groups were compared. Independent sample t test was used for inter-group comparison of the measurement data, paired t test was used for intra-group comparison of the measurement data, and χ² test was used for the count data. Results　Before treatment, there were no statistically significant differences in the mean pure tone threshold and Tinnitus Handicap Inventory (THI) score between the two groups (both P>0.05); after treatment, the mean pure tone threshold and THI score of the observation group were (40.03±3.55) dB and (13.85±2.01) points, respectively, which were lower than those of the control group [(51.95±4.14) dB and (19.95±2.75) points], with statistically significant differences (both P<0.05). There was no statistically significant difference in the incidence of adverse reactions between the two groups (χ²=0.826, P=0.363). The total effective rate of the observation group was 98.75% (79/80), which was higher than that of the control group [90.00% (72/80)], with a statistically significant difference (χ²=4.238, P=0.040). Conclusion　The combined use of methylprednisolone and lidocaine in the clinical treatment of patients with refractory sudden deafness with tinnitus can promote the improvement and recovery of symptoms such as hearing loss and tinnitus, and can reduce the occurrence risk of adverse reactions in patients and improve the efficacy of patients' medication, which is worthy of promotion and application.

Key words:

"> Refractory sudden deafness, Tinnitus, Methylprednisolone, Lidocaine, Therapeutic effect, Mean pure tone threshold

李富云, 薛麦富. 甲泼尼龙和利多卡因治疗难治性突发性聋伴耳鸣的效果[J]. 国际医药卫生导报, 2022, 28(6): 780-783.

Li Fuyun, Xue Maifu. Therapeutic effect of methylprednisolone combined with lidocaine for refractory sudden deafness with tinnitus[J]. International Medicine and Health Guidance News, 2022, 28(6): 780-783.

参考文献

[1] 欧阳杰,黄永望,高晓葳,等. 鼓室注射糖皮质激素治疗伴持续耳鸣的难治性突发性聋疗效观察[J]. 听力学及言语疾病杂志,2018,26(4):347-349. DOI:10.3969/j.issn.1006- 7299.2018.04.003.

[2] 梁碧莹,李希平. 鼓室注射或全身鼓室联合应用糖皮质激素挽救性治疗中重度突发性聋的疗效分析[J]. 临床耳鼻咽喉头颈外科杂志,2020,34(6):536-540. DOI:10.13201/j.issn.2096-7993.2020.06.014.

[3] 谢日林. 同步或序贯静脉应用地塞米松及鼓室内注射甲泼尼龙对突发性耳聋的疗效比较[J]. 中国药物与临床,2019,19(13):2213-2215. DOI:10.11655/zgywylc2019.13.031.

[4] 胡璐璐,闫智强,尹兴红,等. 耳聋左慈丸联合甲泼尼龙治疗突发性耳聋的临床研究[J]. 现代药物与临床,2019,34(9):2690-2693. DOI:10.7501/j.issn.1674-5515.2019.09.025.

[5] 黄颖铭,万保罗,靳钰炜.复方倍他米松联合盐酸利多卡因辅助治疗突发性聋的疗效观察[J].山东大学耳鼻喉眼学报,2018,32(4):11-13.

[6] 蒋中莉,钟时勋. 耳后注射甲泼尼龙治疗低频下降型突发性耳聋的疗效研究[J]. 重庆医学,2020,49(2):277-279,289. DOI:10.3969/j.issn.1671-8348.2020.02.026.

[7] 中华耳鼻咽喉头颈外科杂志编辑委员会,中华医学会耳鼻咽喉头颈外科学分会. 突发性聋的诊断和治疗指南(2005年,济南)[J]. 中华耳鼻咽喉头颈外科杂志,2006,41(8):569. DOI:10.3760/j.issn:1673-0860.2006.08.003.

[8] 刘钊,赵晓明,熊彬彬,等. 鼓室内注射利多卡因联合复合声及心理辅导综合治疗突发性聋伴耳鸣的临床疗效及生活质量分析[J]. 中国耳鼻咽喉头颈外科,2018,25(9):481-484. DOI:10.16066/j.1672-7002.2018.09.006.

[9] 冯彪,程随涛,秦萍. 鼠神经生长因子联合甲泼尼龙治疗突发性耳聋的临床分析[J]. 徐州医科大学学报,2019,39(10):767-770. DOI:10.3969/j.issn.2096-3882.2019.10.016.

[10] 苗英章,安慧琴,宋晓飞,等. 鼓室联合耳后局部应用糖皮质激素治疗难治性突发性聋的临床研究[J]. 河北医药,2018,40(9):1327-1330,1335. DOI:10.3969/j.issn.1002-7386. 2018.09.010.

[11] 杨登化,陈丽艳,赵红,等. 高压氧辅助巴曲酶联合激素治疗难治性突发性聋的疗效分析[J]. 中国医刊,2018,53(9):1040-1043. DOI:10.3969/j.issn.1008-1070.2018.09.025.

[12] 朱艳香,刘文彬,陈菲,等. 鼓室注射甲泼尼龙和利多卡因治疗难治性突发性聋伴耳鸣的临床疗效[J]. 中国临床药学杂志,2020,29(3):169-172. DOI:10.19577/j.1007-4406. 2020.03.003.

甲泼尼龙和利多卡因治疗难治性突发性聋伴耳鸣的效果

Therapeutic effect of methylprednisolone combined with lidocaine for refractory sudden deafness with tinnitus

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 3

编辑推荐

Metrics

[1]	张力峰, 苏泉心, 高生林, 鹿超, 岳闯, 吴兴宇, 毛卫江, 左立. 改良阴茎成形术治疗青少年男性常见外生殖器畸形的疗效分析[J]. 国际医药卫生导报, 2022, 28(6): 745-748.
[2]	叶东明, 赖彩永, 伍国豪, 陈智慧, 钟晓健. 尿管管腔内置斑马导丝对导尿困难患者的治疗效果观察[J]. 国际医药卫生导报, 2022, 28(5): 712-714.
[3]	周珊汕, 吴智丹. 急性肾功能衰竭患者的综合护理干预分析[J]. 国际医药卫生导报, 2022, 28(2): 278-280.